Creteil, France
Professor of Vascular Surgery
University of Paris XII
Department of Vascular Surgery
Henri Mondor Hospital
SCHEDULE FOR VEITHsymposium™
Thursday, November 18, 2010
Presenter
SESSION XVIII: NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
Debate 7: We Still Need A Randomized Controlled Trial (RCT) Of EVAR vs. Open Repair (OR) For Ruptured AAAs: The Ongoing (AJAX And ECAR) Trials Prove It
1:47 PM - 1:52 PM
Saturday, November 20, 2010
Session Moderator
SESSION-XXXIII: NEW DEVELOPMENTS IN THE TREATMENT OF THE AORTA AND ITS BRANCHES (5-MINUTE TALKS)
Presenter
SESSION XXXII: NEW DEVELOPMENTS IN ANEURYSMS AND THEIR TREATMENT: EVAR, THE TRIALS, LAPAROSCOPIC METHODS (5-MINUTE TALKS)
5-Year Results Of The French ACE Trial Comparing EVAR With Open Repair In Standard Risk Patients
7:57 AM - 8:02 AM
Presenter
SESSION XXXIX: VASCULAR DISEASE NATURAL HISTORY, MEDICAL TREATMENT, PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Drug Eluting Stents Are Great For Coronary Artery Disease Patients But Trouble For Vascular Surgeons: How To Get Them Through Surgery If They Have A Drug Eluting Stent
2:46 PM - 2:51 PM
Presenter
SESSION XLI: MORE UPDATES AND NEW TECHNOLOGY (5-MINUTE TALKS)
After EVAR When Is “Fix It And Forget It”, i.e. No Surveillance An Acceptable Strategy?
5:02 PM - 5:07 PM
 
previous next